Clinical Trial Update: Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers

View source ↗

Summary

A clinical trial is recruiting to study subclinical transthyretin cardiac amyloidosis in individuals carrying the V122I TTR mutation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Amyloidosis
• Familial Amyloidosis
• Hereditary Amyloidosis
• Transthyretin-related Familial Amyloid Cardiomyopathy

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Amyloidosis, Hereditary, Amyloidosis Cardiac | Status: RECRUITING